ARGENT BIOPHARMA LIMITED - Announcements

Market Cap $13.79M Add to my watchlist

Healthcare

Argent BioPharma Ltd, formerly MGC Pharmaceuticals Ltd, is an Australia-based drug... Argent BioPharma Ltd, formerly MGC Pharmaceuticals Ltd, is an Australia-based drug discovery company. The Company is focused on developing and supplying accessible and ethically produced plant-derived medicines, combining in-house research with technologies. Its approach combines in-house research with technology, all discovering and producing treatments for unmet medical conditions. Its investigational medicinal (IMPs) products include CannEpil, CimetrA and CogniCann. CimetrA is a phyto medicine based on natural ingredients from Curcumin and Boswellia serrata, delivered in the nanoparticle delivery system, which is being developed for acute lung injury and acute respiratory distress syndrome (ARDS). CannEpil is a phyto medicine based on phytocannabinoid is being developed for the treatment of refractory epilepsy and cerebral palsy. CogniCann is a phyto medicine based on phytocannabinoids is in investigation stage as a treatment for the symptoms associated with dementia and Alzheimer.More

RCE'S BREAKTHROUGH

Synthetic anti-infective developer Recce Pharmaceuticals Ltd (ASX:RCE) has made inroads for recognition of its RECCE® 327 Gel (or R327G) as a topical treatment for burn wound infections, gaining a US$2 million grant from the US Department of Defense...

Announcements

Filter Results

All Price Sensitive Only

RGT	Results of Annual General Meeting		27/11/12	274.28KB	Share
RGT	Becoming a substantial holder		19/11/12	61.6KB	Share
RGT	Investor Presentation November 2012		14/11/12	1.32MB	Share
RGT	Appendix 3Y - Change of Directors Interest Notice		09/11/12	195.5KB	Share
RGT	Significance of Early Exploration Results Confirmed	PRICE SENSITIVE	01/11/12	510.9KB	Share
RGT	September Quarterly Activity and Cashflow Report	PRICE SENSITIVE	29/10/12	852.75KB	Share
RGT	Notice of Annual General Meeting/Proxy Form		23/10/12	581.57KB	Share
RGT	Annual Report 2012		22/10/12	3.62MB	Share
RGT	Senegal Exploration Programme - Initial Results	PRICE SENSITIVE	02/10/12	3MB	Share
RGT	Option Terms and Conditions		27/09/12	206.6KB	Share
RGT	Pro forma Balance Sheet		27/09/12	222.6KB	Share
RGT	Statement of Commitments		27/09/12	212.5KB	Share
RGT	Status of Deed of Asignment and Permits		27/09/12	205.23KB	Share
RGT	Restricted Securities		27/09/12	198.77KB	Share
RGT	Appendix 1A		27/09/12	284.99KB	Share
RGT	Top 20 Shareholders		27/09/12	210.99KB	Share
RGT	Distribution Schedule		27/09/12	199.51KB	Share
RGT	Pre-Reinstatement Disclosure		27/09/12	83.61KB	Share
RGT	ASX Reinstatement Circular		26/09/12	164.13KB	Share
RGT	Reinstatement to Official Quotation - 28 September 2012	PRICE SENSITIVE	26/09/12	77.01KB	Share
RGT	Resignation of Director and Appendix 3Z		25/09/12	238.71KB	Share
RGT	Financial Report for the year ended 30 June 2012		24/09/12	1.2MB	Share
RGT	Update on Reinstatement of Official Quotation		24/09/12	196.03KB	Share
RGT	Form 603 - Initial Substantial Shareholder Notice		19/09/12	33.05KB	Share
RGT	Appendix 3Y - Change of Directors Interest Notice		18/09/12	118.25KB	Share
RGT	Form 604 - Change of Interests of Substantial Holder		17/09/12	186.68KB	Share
RGT	Form 605 - Ceasing to be a Substantial Holder Notice x 4		17/09/12	524.32KB	Share
RGT	Appendix 3Y - Change of Directors Interest Notice x 2		17/09/12	137.42KB	Share
RGT	Appendix 3x and Appendix 3z		14/09/12	124.72KB	Share
RGT	Completion of the Acquisition - Appendix 3B		14/09/12	292KB	Share
RGT	Completion of Capital Raising and Issue of Shares		12/09/12	198.25KB	Share
RGT	Supplementary Prospectus		06/09/12	42.66KB	Share

RGTResults of Annual General Meeting
27/11/12		274.28KB	Share
RGTBecoming a substantial holder
19/11/12		61.6KB	Share
RGTInvestor Presentation November 2012
14/11/12		1.32MB	Share
RGTAppendix 3Y - Change of Directors Interest Notice
09/11/12		195.5KB	Share
RGTSignificance of Early Exploration Results Confirmed
01/11/12	PRICE SENSITIVE	510.9KB	Share
RGTSeptember Quarterly Activity and Cashflow Report
29/10/12	PRICE SENSITIVE	852.75KB	Share
RGTNotice of Annual General Meeting/Proxy Form
23/10/12		581.57KB	Share
RGTAnnual Report 2012
22/10/12		3.62MB	Share
RGTSenegal Exploration Programme - Initial Results
02/10/12	PRICE SENSITIVE	3MB	Share
RGTOption Terms and Conditions
27/09/12		206.6KB	Share
RGTPro forma Balance Sheet
27/09/12		222.6KB	Share
RGTStatement of Commitments
27/09/12		212.5KB	Share
RGTStatus of Deed of Asignment and Permits
27/09/12		205.23KB	Share
RGTRestricted Securities
27/09/12		198.77KB	Share
RGTAppendix 1A
27/09/12		284.99KB	Share
RGTTop 20 Shareholders
27/09/12		210.99KB	Share
RGTDistribution Schedule
27/09/12		199.51KB	Share
RGTPre-Reinstatement Disclosure
27/09/12		83.61KB	Share
RGTASX Reinstatement Circular
26/09/12		164.13KB	Share
RGTReinstatement to Official Quotation - 28 September 2012
26/09/12	PRICE SENSITIVE	77.01KB	Share
RGTResignation of Director and Appendix 3Z
25/09/12		238.71KB	Share
RGTFinancial Report for the year ended 30 June 2012
24/09/12		1.2MB	Share
RGTUpdate on Reinstatement of Official Quotation
24/09/12		196.03KB	Share
RGTForm 603 - Initial Substantial Shareholder Notice
19/09/12		33.05KB	Share
RGTAppendix 3Y - Change of Directors Interest Notice
18/09/12		118.25KB	Share
RGTForm 604 - Change of Interests of Substantial Holder
17/09/12		186.68KB	Share
RGTForm 605 - Ceasing to be a Substantial Holder Notice x 4
17/09/12		524.32KB	Share
RGTAppendix 3Y - Change of Directors Interest Notice x 2
17/09/12		137.42KB	Share
RGTAppendix 3x and Appendix 3z
14/09/12		124.72KB	Share
RGTCompletion of the Acquisition - Appendix 3B
14/09/12		292KB	Share
RGTCompletion of Capital Raising and Issue of Shares
12/09/12		198.25KB	Share
RGTSupplementary Prospectus
06/09/12		42.66KB	Share

REFRESH

First 6 7 8 9 10

(20min delay)
Last 29.5¢		Change 0.010(3.51%)		Mkt cap ! $13.79M

Open	High	Low	Value	Volume
29.5¢	29.5¢	29.5¢	$1.476K	5.002K

Buyers (Bids)

No.	Vol.	Price($)
1	71	28.5¢

Sellers (Offers)

Price($)	Vol.	No.
29.5¢	188	2

View Market Depth

No.	Vol.	Price($)
1	71	0.285
2	11127	0.280
1	7100	0.275
2	13700	0.270
1	2000	0.260

Price($)	Vol.	No.
0.295	185	1
0.300	1000	1
0.310	5530	2
0.320	19200	1
0.370	1056	1

Last trade - 10.07am 30/07/2024 (20 minute delay)

RGT (ASX) Chart

ARGENT BIOPHARMA LIMITED - Announcements

Announcements

Buyers (Bids)

Sellers (Offers)

Top Stories